Bolt Biotherapeutics, Inc.

NasdaqGS:BOLT Rapport sur les actions

Capitalisation boursière : US$25.2m

Bolt Biotherapeutics Dividende

Dividende contrôle des critères 0/6

Bolt Biotherapeutics does not have a record of paying a dividend.

Informations clés

n/a

Rendement du dividende

-0.7%

Rendement des rachats

Rendement total pour l'actionnaire-0.7%
Rendement futur des dividendesn/a
Croissance des dividendesn/a
Prochaine date de paiement du dividenden/a
Date ex-dividenden/a
Dividende par actionn/a
Ratio de distributionn/a

Mises à jour récentes des dividendes

Pas de mise à jour

Recent updates

Little Excitement Around Bolt Biotherapeutics, Inc.'s (NASDAQ:BOLT) Revenues As Shares Take 29% Pounding

May 21
Little Excitement Around Bolt Biotherapeutics, Inc.'s (NASDAQ:BOLT) Revenues As Shares Take 29% Pounding

We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully

Mar 15
We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

May 13
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

Dec 01
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

Bolt Biotherapeutics: A Promised Follow Up

Aug 26

Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08, revenue of $1.39M beats by $0.89M

Aug 10

We're Keeping An Eye On Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate

Jul 27
We're Keeping An Eye On Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate

We're Not Very Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate

Apr 12
We're Not Very Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate

We Think Bolt Biotherapeutics (NASDAQ:BOLT) Can Afford To Drive Business Growth

Dec 03
We Think Bolt Biotherapeutics (NASDAQ:BOLT) Can Afford To Drive Business Growth

Bolt Biotherapeutics: Pioneering A New Class Of Immunotherapies

Aug 18

We're Hopeful That Bolt Biotherapeutics (NASDAQ:BOLT) Will Use Its Cash Wisely

Aug 18
We're Hopeful That Bolt Biotherapeutics (NASDAQ:BOLT) Will Use Its Cash Wisely

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: Insufficient data to determine if BOLT's dividends per share have been stable in the past.

Dividende croissant: Insufficient data to determine if BOLT's dividend payments have been increasing.


Rendement des dividendes par rapport au marché

Bolt Biotherapeutics Rendement des dividendes par rapport au marché
Comment le rendement du dividende de BOLT se compare-t-il à celui du marché ?
SegmentRendement du dividende
Entreprise (BOLT)n/a
25% du marché (US)1.5%
25% du marché (US)4.5%
Moyenne du secteur (Biotechs)2.2%
Analyste prévisionnel (BOLT) (jusqu'à 3 ans)n/a

Dividende notable: Unable to evaluate BOLT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Dividende élevé: Unable to evaluate BOLT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Bénéfice distribué aux actionnaires

Couverture des revenus: Insufficient data to calculate BOLT's payout ratio to determine if its dividend payments are covered by earnings.


Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as BOLT has not reported any payouts.


Découvrir des entreprises qui versent des dividendes élevés